Please don't take this the wrong way because I'm as optimistic about the upside of RVX as the next person.  However, I'm beginning to think that nothing will really drive this stock forward except a buyout.  In spite of general optimism on some of the BoM results, DM's upbeat attitude and favorably sounding PRs the market's reaction has been one great big snorefest.  Maybe the CTAD, which don't forget is still only a sub-study, if positive will cause a few of the masses to stir or turn over but I'm no longer holding my breath for any significant impact on the SP.

This company just doesn't seem to be on anyone's radar except for those that already have an interest in it.  Maybe the only people that can really appreciate the true potential that RVX has are BP researchers and other pharmaceutical and medical gurus that really understand the science behind all this and what that portends in terms of medical benefits and future revenues.

Those of us on this board are living in a bit of a bubble compared to the masses.  We have much more information than the average joe simply because we put this company under a microscope.  But anyone else out there in investorland probably has no clue.  Because of it's tightly held ownership structure this stock is so thinly traded its virtually impossible (IMO) to try and predict anything as to what the SP might do.

So yes, go CTAD and go DM and team in terms of continuing to add value to RVX where possible.  But I think the potential big bucks lie with BP and not with this obsure little Canadian biotech that nobody has ever heard of.  Isn't that why they call them 'Big Pharma'?